National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
October 20, 2009 • Volume 6 / Number 20

The information and links on this page are no longer being updated and are provided for reference purposes only.

NEWS

Cancer cells found in the blood of a child with acute lymphoblastic leukemia. Better Options for Children with Difficult-to-Treat Leukemia

Some young patients with forms of acute lymphoblastic leukemia (ALL) that do not respond to current treatments may have new options, according to two clinical trials published online October 5 in the Journal of Clinical Oncology. Both trials were led by the NCI-supported Children's Oncology Group (COG), and each yielded impressive results for patients with difficult-to-treat cancers. Read more > >

COMMENTARY

Dr. James H. Doroshow

Guest Director's Update: The NExT Steps in Drug Development at NCI

by Dr. James H. Doroshow

The FDA's recent approval of the new agent pralatrexate (Folotyn) for the treatment of peripheral T-cell lymphoma (PTCL) was especially satisfying news for those of us at NCI who have been involved with this drug. Of course, we are always pleased to see a new, effective cancer treatment reach the clinic, especially one for patients with this rare form of lymphoma who have relapsed after or failed to respond to their initial treatment. Read more > >

IN DEPTH

UPDATES

  • Legislative Update

    • Experts Testify on Pending Breast Cancer Legislation
    • Congressional Delegation Visits NIH
  • FDA Update

    • FDA Approves Two HPV Vaccines: Cervarix for Girls, Gardasil for Boys
    • FDA Approves New Targeted Therapy for Kidney Cancer

    Notes

    • NIH Mourns Passing of Former Acting Director Dr. Ruth Kirschstein
    • NCI Cancer Bulletin Recognized with NIH Merit Award
    • International Palliative Care Resources Available Online

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information about cancer, call 1-800-4-CANCER or visit .

NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.

Next Section >